Medicines safety notices

July 21, 2023

We have six drug safety notices from our pharmacy department which clinical colleagues should be aware of.

Amiodarone 300mg/10mL solution for injection/infusion in a 10mL pre-filled syringe is out of stock until early August 2023.
Very limited supplies of all glucagon-like peptide-1 receptor agonists (GLP-1 RAs) licensed in the management of Type 2 diabetes. Supply is not expected to return to normal until at least mid-2024.
Lidocaine 1% with adrenaline 1 in 200,000 injection and Lidocaine 2% with adrenaline is in short supply until December 2023.
There is a current shortage of Selegiline 5mg and 10mg tablets with supplies not anticipated until end of July at the earliest. Pharmacy have limited supplies remaining.
The manufacturer of Tresiba (insulin degludec) 100units/mL FlexTouch pen are currently experiencing a shortage which is expected to last from August 2023 until January 2024. Other presentations of Tresiba, including within other insulin pens, are unaffected by the shortage

Please see information sheets below for further advice and alternatives:

For more information please contact the pharmacy department on ext. 5263/3783.